Science Explorer Interactive view Map
Company · Cork · Ireland

Novartis (Ireland)

World rank, 2022–2025
#22,817
of 28,054 · #31,391 all time
Rank in Ireland
#65
of 79
Research works
160
▲ 107% vs 2013–17
Citations
1.7k
10.3 per fractional work
Top-10% rate
9.4%
record average 16.5%
Open access
51%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.35× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 0.64× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 3.65× its world share, 3 worksImmunology and Micro…Neuroscience: 0.59× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 1.60× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.53× its world share, 1 worksChemistryComputer Science: 0.07× its world share, 0 worksComputer ScienceEngineering: 0.20× its world share, 2 worksEngineeringEnvironmental Science: 0.08× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.03× its world share, 0 worksMaterials ScienceMathematics: 0.84× its world share, 1 worksMathematicsHealth Professions: 1.50× its world share, 3 worksHealth ProfessionsMedicine: 3.38× its world share, 46 worksMedicineVeterinary: 0.86× its world share, 0 worksVeterinaryArts and Humanities: 0.06× its world share, 0 worksArts and HumanitiesDecision Sciences: 1.01× its world share, 1 worksDecision SciencesEconomics, Econometrics and Finance: 5.37× its world share, 8 worksEconomics, Econometr…Psychology: 0.25× its world share, 0 worksPsychologySocial Sciences: 0.11× its world share, 1 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Economics, Econometrics and Finance, 5.4×. Every wedge is a field page.

Which keywords describe research at Novartis (Ireland)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Quality of Life, Autoantibodies, Cost-effectiveness Analysis, Health Utility Measures, Diagnosis, Epidemiology, Inflammation and Clinical Trials.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Quality of Life10▲ 9.6×12 topics
  2. Epidemiology8▲ 2.6×28 topics
  3. Autoantibodies6▲ 34×5 topics
  4. Cost-effectiveness Analysis6▲ 92×1 topic
  5. Health Utility Measures6▲ 92×1 topic
  6. Inflammation5▲ 3.7×18 topics
  7. Diagnosis5▲ 7.4×9 topics
  8. Clinical Trials4▲ 7.7×10 topics
  9. Treatment4▲ 4.3×13 topics
  10. Autoimmune4▲ 103×2 topics
  11. Management3▲ 5.9×7 topics
  12. BCR-ABL3▲ 162×1 topic
  13. Imatinib3▲ 162×1 topic
  14. Rituximab3▲ 29×4 topics
  15. Immunosuppressive Therapy3▲ 23×5 topics
  16. Chronic Spontaneous Urticaria2▲ 151×1 topic
  17. Urticaria2▲ 151×1 topic
  18. Diagnostic Criteria2▲ 15×4 topics
  19. Global Prevalence2▲ 35×2 topics
  20. Visual Impairment2▲ 67×2 topics
  21. Myopia2▲ 53×1 topic
  22. Refractive Error2▲ 82×1 topic
  23. Thrombosis2▲ 11×5 topics
  24. Biomarkers2▲ 4.0×6 topics
  25. Cardiovascular Disease Prevention2▲ 32×2 topics
  26. Cytokines2▲ 9.3×3 topics
  27. Genetic Variants2▲ 15×3 topics
  28. Prognostic Factors2▲ 5.8×6 topics
  29. Health Outcomes2▲ 8.8×4 topics
  30. Lymphoma2▲ 15×3 topics
  31. Intravenous Immunoglobulin2▲ 34×3 topics
  32. Statins2▲ 29×2 topics
  33. Cholesterol-lowering1▲ 43×1 topic
  34. Cognitive Impairment1▲ 7.5×3 topics
  35. LDL Cholesterol1▲ 57×1 topic
  36. Pharmaceutical Industry1▲ 50×2 topics
  37. Chronic Disease Management1▲ 9.4×5 topics
  38. Drug Development Costs1▲ 68×1 topic
  39. Generic Drugs1▲ 68×1 topic
  40. Breast Cancer1▲ 7.3×5 topics

Which research topics does Novartis (Ireland) publish most on?

By volume in 2022–2025: Health Systems, Economic Evaluations, Quality of Life, Chronic Myeloid Leukemia Treatments, Urticaria and Related Conditions and Ophthalmology and Visual Impairment Studies.

  1. 1 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 6 works
  2. 2 Chronic Myeloid Leukemia Treatments Hematology 3 works
  3. 3 Urticaria and Related Conditions Rheumatology 2 works
  4. 4 Ophthalmology and Visual Impairment Studies Epidemiology 2 works
  5. 5 Lipoproteins and Cardiovascular Health Surgery 1 works
  6. 6 Pharmaceutical Economics and Policy Economics and Econometrics 1 works
  7. 7 Coagulation, Bradykinin, Polyphosphates, and Angioedema Genetics 1 works
  8. 8 Multiple Sclerosis Research Studies Pathology and Forensic Medicine 1 works
  9. 9 Autoimmune Bullous Skin Diseases Pathology and Forensic Medicine 1 works
  10. 10 Biomedical and Engineering Education Biomedical Engineering 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available51.2%not open48.8%

World: 28% of research is openly available.

with international co-authors86.8%domestic only13.2%

World: 19% is written across borders.

How has Novartis (Ireland)'s research output changed?

Output in 2018–2022 was 107% higher than in 2013–2017.

200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Cork

All research institutions in Cork

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.